Webinar

From stem cells to neurons: advancing Parkinson’s research toward therapies

The keynote speaker, Dr. Mark Denham from Aarhus University Hospital will share how his team genetically modified human pluripotent stem cells to create lineage-restricted undifferentiated stem cells. These cells are designed to efficiently generate mesencephalic dopaminergic neurons while preventing off-target differentiation.

What you’ll learn

• How lineage-restricted iPSCs can improve dopaminergic neural differentiation efficiency
• Insights into translating stem cell research toward future Parkinson’s therapies
• How Pluristyx and BioLamina are partnering to enable defined, scalable stem cell systems that support the path to therapy